Genmab and Merus had announced today that they have entered into a transaction agreement pursuant to which Genmab intends to acquire all the shares of Merus, a clinical-stage biotechnology company...

Akero Therapeutics, Inc. a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that it has...

BioCryst Pharmaceuticals, Inc. announced it will acquire Astria Therapeutics, Inc., a biopharma company specializing in allergic and immunologic disease therapies, in a cash-and-stock deal valued at...

Novartis has signed an agreement for the acquisition of all outstanding shares of US-based Avidity Biosciences for $12bn in cash on a fully diluted basis. This represents an enterprise value of...